BFC Planning’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$821K Buy
3,899
+898
+30% +$180K 0.03% 447
2026
Q2
$571K Buy
3,001
+274
+10% +$47.1K 0.02% 566
2026
Q1
$461K Sell
2,727
-1,092
-29% -$187K 0.02% 595
2025
Q4
$645K Sell
3,819
-3,175
-45% -$516K 0.03% 479
2025
Q3
$1.01M Sell
6,994
-2,520
-26% -$344K 0.07% 232
2025
Q2
$1.2M Buy
9,514
+481
+5% +$59K 0.09% 196
2025
Q1
$1.16M Buy
9,033
+2,900
+47% +$393K 0.1% 180
2024
Q4
$811K Sell
6,133
-1,758
-22% -$247K 0.07% 237
2024
Q3
$1.15M Buy
+7,891
New +$1.14M 0.1% 188

Other funds holding IBB

BFC Planning's IBB Position: Q3 2026 in Review

BFC Planning increased its iShares Biotechnology ETF (IBB) stake by 30% in Q3 2026, buying an estimated $180K and bringing the position to 3,899 shares worth $821K. The position accounts for 0.03% of the portfolio, ranked #447.

BFC Planning first reported a position in IBB in Q3 2024 and has held it in 9 quarters since. The position peaked at $1.2M in Q2 2025. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • BFC Planning held 3,899 shares of iShares Biotechnology ETF worth $821K as of Q3 2026.
  • BFC Planning bought 898 iShares Biotechnology ETF shares in Q3 2026, an estimated $180K.
  • iShares Biotechnology ETF made up 0.03% of BFC Planning's portfolio in Q3 2026, its #447 holding.
  • BFC Planning first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's iShares Biotechnology ETF position peaked at $1.2M in Q2 2025.
  • 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.